Answers from the Lab

Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation sequencing and complements the laboratory's cell-based cancer testing.

Show Notes

(00:31)
 Could you each provide us a little bit about yourself and your background? Dr. Zheng, we'll start with you.

(01:40)
 Dr. Mansfield, how about you?

(02:07) 
 Could you explain a little bit about the new biopsy test and the technology?

(03:58)
 Which patients should have this testing and when should it be used?

(06:44)
 What alternative test options are available and how would they compare to the Mayo complete cell-free DNA panel?

(08:28)
 Can you go into a little more detail from a clinical practice perspective about how these tests are used?

(10:16)
 Dr. Zheng, is there anything else you would like to add to this discussion?

(10:53)
 Dr. Mansfield, is there anything else you would like to add to this discussion?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.